TR109 (stage IVA, adenocarcinoma, 59-year-old male with meningeoma angiomatosum gradus 1) has a BAX frame-shift mutation c.121dup characterized as pathogenic and with high impact on protein function and reported in carcinoma of colon, and inborn genetic diseases. The gene discussed is BAX; the disease is colon carcinoma.